10 years ago, St. Jude took on pediatric cancer genome, and won

By Updated: February 12, 2020 1:20 PM CT | Published: February 10, 2020 4:00 AM CT
<strong>Dr. James Downing, president and CEO of St. Jude Children’s Research Hospital, has been instrumental in the development and refinement of St. Jude’s genomic sequencing operations for pediatric cancer.&nbsp;</strong>(Patrick Lantrip/Daily Memphian)

Dr. James Downing, president and CEO of St. Jude Children’s Research Hospital, has been instrumental in the development and refinement of St. Jude’s genomic sequencing operations for pediatric cancer. (Patrick Lantrip/Daily Memphian)

Topics

Dr. James Downing St. Jude Children’s Research Hospital Pediatric Cancer Genome Project
Jane Roberts

Jane Roberts

Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers healthcare and higher education for The Daily Memphian.


Comment On This Story

Section Emails

Sign up to get the latest articles from the Business section.